Albouy M., Parthenay M., Nogues M., Leyris A., Degorce L., Barthelemy Z., Rafidison D., Gourgues A.-S., Migeot V., Pylouster J., Dupuis A. (2022). A Clinical Preventive Strategy Based on a Digital Tool to Improve Access to Endocrine Disruptors Exposure Prevention: The MEDPREVED Study. International Journal of Environmental Research and Public Health 19 (19): 11993. doi:3390/ijerph191911993
Blanc T., Meignan P., Vinit N., Ballouhey Q., Pio L., Capito C., Harte C., Vatta F., Galmiche-Rolland L., Minard V., Orbach D., Berteloot L., Muller C., Kohaut J., Broch A., Braik K., Binet A., Heloury Y., Fourcade L., Lardy H., Sarnacki S. (2022). Robotic Surgery in Pediatric Oncology: Lessons Learned from the First 100 Tumors—A Nationwide Experience. Annals of Surgical Oncology 29 (2): 1315–1326. doi:1245/s10434-021-10777-6
Desmarchais A., Téteau O., Kasal-Hoc N., Cognié J., Lasserre O., Papillier P., Lacroix M., Vignault C., Jarrier-Gaillard P., Maillard V., Binet A., Pellicer-Rubio M.-T., Fréret S., Elis S. (2022). Chronic low BPS exposure through diet impairs in vitro embryo production parameters according to metabolic status in the ewe. Ecotoxicology and Environmental Safety 229: 113096. doi:1016/j.ecoenv.2021.113096
El Ouazzani H., Fortin S., Venisse N., Dupuis A., Rouillon S., Cambien G., Gourgues A.-S., Pierre-Eugène P., Rabouan S., Migeot V., Albouy-Llaty M. (2021). Perinatal Environmental Health Education Intervention to Reduce Exposure to Endocrine Disruptors: The PREVED Project. International Journal of Environmental Research and Public Health 19 (1): 70. doi:3390/ijerph19010070
Ferrero P.A., Blanc T., Binet A., Arnaud A., Abbo O., Vatta F., Bonnard A., Spampinato G., Lardy H., Fourcade L., Ballouhey Q. (2022). The Potential and the Limitations of Esophageal Robotic Surgery in Children. European Journal of Pediatric Surgery 32 (02): 170–176. doi:1055/s-0040-1721770
Hocqueloux L., Lefeuvre S., Bois J., Brucato S., Alix A., Valentin C., Peyro-Saint-Paul L., Got L., Fournel F., Dargere S., Prazuck T., Fournier A., Gregoire N., McNicholl I., Parienti J.-J. (2023). Bioavailability of dissolved and crushed single tablets of bictegravir, emtricitabine, tenofovir alafenamide in healthy adults: the SOLUBIC randomized crossover study. Journal of Antimicrobial Chemotherapy 78 (1): 161–168. doi:1093/jac/dkac369
Kably B., Launay M., Derobertmasure A., Lefeuvre S., Dannaoui E., Billaud E.M. (2022). Antifungal Drugs TDM: Trends and Update. Therapeutic Drug Monitoring 44 (1): 166–197. doi:1097/FTD.0000000000000952
Marc S., Mésangeau C., Coevoet M., Barczyk A., Burlet S., Verwaerde P., Estrella C., Brantis C., Sergeant N., Carato P., Melnyk P. (2022). Pharmacomodulations around an anti-Alzheimer drug-candidate. European Journal of Medicinal Chemistry Reports 4: 100020. doi:1016/j.ejmcr.2021.100020
Marques dos Santos M., Cheriaux C., Jia S., Thomas M., Gallard H., Croué J.-P., Carato P., Snyder S.A. (2022). Genotoxic effects of chlorinated disinfection by-products of 1,3-diphenylguanidine (DPG): Cell-based in-vitro testing and formation potential during water disinfection. Journal of Hazardous Materials 436: 129114. doi:1016/j.jhazmat.2022.129114
Mesangeau C., Carato P., Renault N., Coevoet M., Larchanché P.-E., Barczyk A., Buée L., Sergeant N., Melnyk P. (2022). Discovery of Compounds That Selectively Repress the Amyloidogenic Processing of the Amyloid Precursor Protein: Design, Synthesis and Pharmacological Evaluation of Diphenylpyrazoles. International Journal of Molecular Sciences 23 (21): 13111. doi:3390/ijms232113111
Migeot V., Guihenneuc J., Ouazzani H.E., Albouy M., Dupuis A., Rabouan S. (2022). Risk and asset-based strategies in health: priorities in biomedical, life and environmental science literature since the early twentieth century. A rapid review. Environmental Health 21 (1): 22. doi:1186/s12940-022-00833-3
Mukendi-Nkesu Y., Machet M.-C., Binet A., Édée É., Maruani A. (2022). Sacrococcygeal Mass in a Newborn: A Quiz. Acta Dermato-Venereologica 102: adv00782. doi:2340/actadv.v102.3934
Plattard N., Gnanasegaran R., Krekesheva A., Carato P., Dupuis A., Migeot V., Albouy M., Haddad S., Venisse N. (2023). Quantification of the Conjugated Forms of Dichlorobisphenol A (3,3′-Cl2BPA) in Rat and Human Plasma Using HPLC-MS/MS. Therapeutic Drug Monitoring 45 (4): 554–561. doi:1097/FTD.0000000000001074
Plattard N., Venisse N., Carato P., Dupuis A., Haddad S. (2022). Hepatic metabolism of chlorinated derivatives of bisphenol A (ClxBPA) and interspecies differences between rats and humans. Archives of Toxicology. doi:1007/s00204-021-03217-7
Robin J., Binson G., Albouy M., Sauvaget A., Pierre-Eugène P., Migeot V., Dupuis A., Venisse N. (2022). Analytical method for the biomonitoring of bisphenols and parabens by liquid chromatography coupled to tandem mass spectrometry in human hair. Ecotoxicology and Environmental Safety 243: 113986. doi:1016/j.ecoenv.2022.113986
Téteau O., Liere P., Pianos A., Desmarchais A., Lasserre O., Papillier P., Vignault C., Lebachelier de la Riviere M.-E., Maillard V., Binet A., Uzbekova S., Saint-Dizier M., Elis S. (2022). Bisphenol S Alters the Steroidome in the Preovulatory Follicle, Oviduct Fluid and Plasma in Ewes With Contrasted Metabolic Status. Frontiers in Endocrinology 13: 892213. doi:3389/fendo.2022.892213
Vignault C., Cadoret V., Jarrier-Gaillard P., Papillier P., Téteau O., Desmarchais A., Uzbekova S., Binet A., Guérif F., Elis S., Maillard V. (2022). Bisphenol S Impairs Oestradiol Secretion during In Vitro Basal Folliculogenesis in a Mono-Ovulatory Species Model. Toxics 10 (8): 437. doi:3390/toxics10080437
2023
Albouy M., Deceuninck Y., Migeot V., Doumas M., Dupuis A., Venisse N., Engene P.P., Veyrand B., Geny T., Marchand P., Le Bizec B., Bichon E., Carato P. (2023). Characterization of pregnant women exposure to halogenated parabens and bisphenols through water consumption. Journal of Hazardous Materials 448: 130945. doi:1016/j.jhazmat.2023.130945
Benlaassri M., Ecale F., Crepin A., Rodier M.-H., Venisse N., Cateau E. (2023). In vitro reciprocal interactions between yeasts from human cutaneous mycobiota and parabens used in cosmetics. FEMS Microbiology Letters 370: fnac124. doi:1093/femsle/fnac124
Cambien G., Dupuis A., Guihenneuc J., Bauwens M., Belmouaz M., Ayraud-Thevenot S. (2023). Endocrine disruptors in dialysis therapies: A literature review. Environment International 178: 108100. doi:1016/j.envint.2023.108100
Guihenneuc J., Ayraud-Thevenot S., Roschnik S., Dupuis A., Migeot V. (2023). Climate change and health care facilities: A risk analysis framework through a mapping review. Environmental Research 216: 114709. doi:1016/j.envres.2022.114709
Marco L., Cambien G., Garcia M., Broutin L., Cateau E., Lariviere A., Castel O., Thevenot S., Bousseau A. (2023). Les infections respiratoires : prévention de la transmission en milieu de soins. Revue des Maladies Respiratoires 40 (7): 572–603. doi:1016/j.rmr.2023.05.001
Plattard N., Gnanasegaran R., Krekesheva A., Carato P., Dupuis A., Migeot V., Albouy M., Haddad S., Venisse N. (2023). Quantification of the Conjugated Forms of Dichlorobisphenol A (3,3′-Cl2BPA) in Rat and Human Plasma Using HPLC-MS/MS. Therapeutic Drug Monitoring 45 (4): 554–561. doi:1097/FTD.0000000000001074
Revol B., Willeman T., Manceau M., Dumestre-Toulet V., Gaulier J.-M., Fouilhé Sam-Laï N., Eysseric-Guérin H., Compagnie Nationale des Biologistes et Analystes Experts (CNBAE) and the French Addictovigilance Network (FAN), Abbara C., Allorge D., Alvarez J.-C., Ameline A., Aquizerate A., Barret A., Berland E., Bertin C., Besnard T., Bevalot F., Billet-Chatenay C., Bouquet E., Bourgine J., Brunet B., Caous A.-S., Cesbron A., Chaouachi L., Chevallier C., Cheze M., Citterio-Quentin A., Collon-Fabie P., Dailly E., Daveluy A., Deffontaine G., Delage M., Delavenne X., Descamps F., Descoeur J., Deslandes G., Deveaux M., Devos B., Doche C., Eiden C., Fouley A., Gaillard Y., Gambier N., Ganière C., Goullé J.-P., Guerard P., Hoizey G., Humbert L., Imbert L., Kergueris M.-F., Kintz P., Klinzig F., Labat-Deveaux L., Lacarelle B., Lacroix C., Lamiable D., Lavit M., Le Boisselier R., Le Bouil A., Le Meur C., Lefeuvre S., Lelièvre B., Lelong-Boulouard V., Lemaire-Hurtel A.-S., Lima-Tournebize J., Loilier M., Lopez V., Martin-Molins C., Marty H., Mathieu O., Mathieu-Daudé J.-C., Mauras Y., Milan N., Moal A., Morel I., Mura P., Pelissier-Alicot A.-L., Pépin G., Perrin M., Peyre A., Pineau A., Pok R., Ragoucy-Sengler C., Rayer R., Roman E., Roussel C., Roussin A., Sabini S., Saussereau E., Scala-Bertola J., Sibille P., Spadari M., Titier K., Turcant A., Vacher P., Venisse N., Vieira O., Visinoni P. (2023). Trends in Fatal Poisoning Among Drug Users in France From 2011 to 2021: An Analysis of the DRAMES Register. JAMA Network Open 6 (8): e2331398. doi:1001/jamanetworkopen.2023.31398
Thiroux A., Labanowski J., Venisse N., Crapart S., Boisgrollier C., Linares C., Berjeaud J., Villéger R., Crépin A. (2023). Exposure to endocrine disruptors promotes biofilm formation and contributes to increased virulence of Pseudomonas aeruginosa. Environmental Microbiology Reports 15 (6): 740–756. doi:1111/1758-2229.13190
2024
Adamo-Croux M., Auger-Gilli A., Guyader G.L., Aubin-Courjault J., Margot H., Bar C., Lacombe D., Van-Gils J., Legendre M., Binet A., Horn X.L.G. (2024). Care pathways in childhood neurodevelopmental disorders: Toward greater awareness of KBG syndrome among pediatricians. Archives de Pédiatrie 31 (5): 320–325. doi:1016/j.arcped.2024.02.007
Albouy M., Rusch E., Aubry J.-D., Margat A., Gagnayre R. (2024). L’éducation thérapeutique du patient, une intervention de promotion de la santé: Santé Publique 36 (5): 9–13. doi:3917/spub.245.0009
Cambien G., Dupuis A., Belmouaz M., Bauwens M., Bacle A., Ragot S., Migeot V., Albouy M., Ayraud-Thevenot S. (2024). Bisphenol A and chlorinated derivatives of bisphenol A assessment in end stage renal disease patients: Impact of dialysis therapy. Ecotoxicology and Environmental Safety 270: 115880. doi:1016/j.ecoenv.2023.115880
Guihenneuc J., Cambien G., Blanc-Petitjean P., Papin E., Bernard N., Jourdain B., Barcos I., Saez C., Dupuis A., Ayraud-Thevenot S., Migeot V. (2024). Knowledge, behaviours, practices, and expectations regarding climate change and environmental sustainability among health workers in France: a multicentre, cross-sectional study. The Lancet Planetary Health 8 (6): e353–e364. doi:1016/S2542-5196(24)00099-8
Lebachelier De La Riviere M.-E., Téteau O., Mahé C., Lasserre O., Desmarchais A., Uzbekova S., Papillier P., Tomas D., Labas V., Maillard V., Saint-Dizier M., Binet A., Elis S. (2024). Metabolic status is a key factor influencing proteomic changes in ewe granulosa cells induced by chronic BPS exposure. BMC Genomics 25 (1): 1095. doi:1186/s12864-024-11034-2
Lefeuvre S., Richeval C., Lelong J., Venisse N., Humbert L., Brunet B. (2024). N-Ethylhexedrone: A very long and bad trip! A case series. Journal of Analytical Toxicology 48 (7): 507–513. doi:1093/jat/bkae040
Lemaitre F., Lagoutte‐Renosi J., Gagnieu M., Parant F., Venisse N., Grégoire M., Bouchet S., Garraffo R., Lê M.P., Muret P., Comets E., Solas C., Peytavin G., the ANRS‐MIE‐BIRIDER Study group on behalf of the Clinical Pharmacology Group of ANRS‐MIE AC43. (2024). Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV‐1‐infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS‐MIE‐BIRIDER study). British Journal of Clinical Pharmacology 90 (1): 264–273. doi:1111/bcp.15890
Marques Dos Santos M., Li C., Jia S., Thomas M., Gallard H., Croué J.-P., Carato P., Snyder S.A. (2024). Formation of halogenated forms of bisphenol A (BPA) in water: Resolving isomers with ion mobility – mass spectrometry and the role of halogenation position in cellular toxicity. Journal of Hazardous Materials 465: 133229. doi:1016/j.jhazmat.2023.133229
Martin M., Ayraud-Thevenot S., Dufour X., Lebreton J.-P., Guihenneuc J., Carsuzaa F. (2025). Environmental impact of pediatric ENT surgery: A STROBE analysis. European Annals of Otorhinolaryngology, Head and Neck Diseases 142 (2): 74–78. doi:1016/j.anorl.2024.11.005
Ramsamy G., Esnard C., STEREOBES Consortium, Mosbah H., Soussi Berjonval D., Faure J.P., Albouy M. (2024a). Effect of a patient education program focused on weight stigma on quality of life and self-efficacy in patients living with obesity: study protocol for a randomized controlled trial. BMC Psychology 12 (1): 734. doi:1186/s40359-024-02274-8
Ramsamy G., Mosbah H., Faure J.P., Plault V., Albouy M., Esnard C. (2024b). How to reduce the adverse effects of weight stigma on the quality of life: a preferred reported items for systematic reviews and meta-analyses (PRISMA). Frontiers in Psychology 15: 1421609. doi:3389/fpsyg.2024.1421609
Revol B., Willeman T., Manceau M., Dumestre-Toulet V., Gaulier J.-M., Eysseric-Guérin H., Fouilhé Sam-Laï N., Abbara C., Allorge D., Alvarez J.-C., Ameline A., Barret A., Berland E., Bertin C., Besnard T., Bevalot F., Billet-Chatenay C., Boucher A., Bouquet E., Bourgine J., Brunet B., Caous A.-S., Cesbron A., Charuel L., Cheze M., Citterio-Quentin A., Collon-Fabie P., Dailly E., Daveluy A., Deffontaine G., Delage M., Delavenne X., Descamps F., Descoeur J., Deslandes G., Deveaux M., Devos B., Doche C., Eiden C., Fouley A., Gaillard Y., Gambier N., Ganière C., Gérardin M., Goullé J.-P., Guerard P., Hoizey G., Humbert L., Imbert L., Kergueris M.-F., Kintz P., Klinzig F., Labat-Deveaux L., Lacarelle B., Lacroix C., Lamiable D., Lavit M., Le Boisselier R., Le Bouil A., Le Meur C., Lefeuvre S., Lelièvre B., Lelong-Boulouard V., Lemaire-Hurtel A.-S., Loilier M., Lopez V., Martin-Molins C., Marty H., Mathieu O., Mathieu-Daudé J.-C., Mauras Y., Milan N., Moal A., Morel I., Mura P., Pelissier-Alicot A.-L., Pépin G., Perrin M., Peyre A., Pineau A., Pochard L., Pok R., Ragoucy-Sengler C., Rayer R., Redjimi N., Roman E., Roussel C., Sabini S., Saussereau E., Scala-Bertola J., Sibille P., Spadari M., Thiery J., Titier K., Turcant A., Vacher P., Venisse N., Vieira O., Visinoni P. (2024). Trends in fatal poisoning among medical users of analgesics in France from 2013 to 2022: an analysis of the DTA register. Public Health 236: 381–385. doi:1016/j.puhe.2024.08.019
Robin J., Albouy M., Jourdain B., Binson G., Sauvaget A., Pierre-Eugène P., Wu L., Migeot V., Dupuis A., Venisse N. (2024a). Assessment of Endocrine Disruptor Exposure in Hospital Professionals Using Hair and Urine Analyses: An Awareness Campaign. Therapeutic Drug Monitoring 46 (1): 102–110. doi:1097/FTD.0000000000001132
Robin J., Lefeuvre S., Guihenneuc J., Cambien G., Dupuis A., Venisse N. (2024b). Analytical methods and biomonitoring results in hair for the assessment of exposure to endocrine-disrupting chemicals: A literature review. Chemosphere 353: 141523. doi:1016/j.chemosphere.2024.141523
Rullier A., Guihenneuc J., Ayraud-Thevenot S., Jourdain B., Boissinot L., Le Gonidec P., Deit A., Morisson C., Andicoéchéa C., Bernard N. (2024). CAP, comprendre, agir et partager : une boite à outils made in Nouvelle Aquitaine pour accompagner les établissements dans leur transformation écologique. Annales de Pathologie 44 (5): 331–337. doi:1016/j.annpat.2024.08.005
Suteau V., Zuzic L., Hansen D.H., Kjølbye L.R., Sibilia P., Gourdin L., Briet C., Thomas M., Bourdeaud E., Tricoire-Leignel H., Schiøtt B., Carato P., Rodien P., Munier M. (2024). Effects and risk assessment of halogenated bisphenol A derivatives on human follicle stimulating hormone receptor: An interdisciplinary study. Journal of Hazardous Materials 479: 135619. doi:1016/j.jhazmat.2024.135619
Zoppé H., Xavier J., Dupuis A., Migeot V., Bioulac S., Hary R., Bonnet-Brilhault F., Albouy M. (2024). Is exposure to Bisphenol A associated with Attention-deficit hyperactivity disorder (ADHD) and associated executive or behavioral problems in children? A comprehensive systematic review. Neuroscience & Biobehavioral Reviews 167: 105938. doi:1016/j.neubiorev.2024.105938
2025
Belmouaz M., Dibon C., Devaux J.-P., Duthe F., Wong-Cheng R., Lemarchand C., Ecotiere L., Gombert J.-M., Jacomet F., Ayraud-Thevenot S., Durocher L., Thierry A., Saulnier P.-J., Bridoux F. (2025). Effect of Reduced Dialysate Flow on Dialysis Adequacy: A Pilot Study. Blood Purification 55 (2): 138–147. doi:1159/000549110
Carli L., Marchand C., Albouy M., Faure J.-P., Crozet C. (2025). Étude préalable à la mise en place d’un programme d’éducation thérapeutique, réalisé en simulation sur le département de La Vienne (86) en France. Education Thérapeutique du Patient – Therapeutic Patient Education 17 (2): 20201. doi:1051/tpe/2025011
Carsuzaa F., Ayraud-Thevenot S., Dufour X., Guihenneuc J., Favier V. (2025). Impact of drug-induced sleep endoscopy on sustainability: A STROBE-analysis. European Annals of Otorhinolaryngology, Head and Neck Diseases S1879729625001395. doi:1016/j.anorl.2025.10.001
Chevais M., Rabouam L., Airaud C., Dessane B., Binson G., Dupuis A. (2025). New softgel used as a device to ensure safe oral administration in the pediatric population. Journal of Drug Delivery Science and Technology 103: 106389. doi:1016/j.jddst.2024.106389
Cros F., Hirschauer C., Morton-Fauche C., Thomet A., Albouy M., Binet A. (2025). Pediatric urinary health and school health conditions in France: A political urgency? Journal of Pediatric Urology 21 (6): 1820–1828. doi:1016/j.jpurol.2025.07.024
Devaux A., Villéger R., Roche G., Diémé B., Rodrigues M., Juban C., Lagrée M., Venisse N., Jousse C., Barnich N., Bonnet M. (2025). L-serine promotes pro-carcinogenic effects of colibactin-producing coli. Gut Microbes 17 (1): 2515480. doi:10.1080/19490976.2025.2515480
Guihenneuc J., Ayraud-Thevenot S., Lecronier M., Boissier F., Poissy J. (2025). Sustainable development and intensive care medicine: high time for implementing education tools! Intensive Care Medicine 51 (11): 2152–2155. doi:1007/s00134-025-08147-x
Lebachelier De La Riviere M.-E., Bousquet M., Tavernier E., Maillard V., Desmarchais A., Uzbekova S., Guérif F., Binet A., Elis S. (2025). Effects of Bisphenols on the Assisted Reproductive Technology Outcomes Considering the Patient Clinical Parameters. Journal of the Endocrine Society 9 (6): bvaf066. doi:1210/jendso/bvaf066
Martin M., Ayraud-Thevenot S., Dufour X., Lebreton J.-P., Guihenneuc J., Carsuzaa F. (2025). Environmental impact of pediatric ENT surgery: A STROBE analysis. European Annals of Otorhinolaryngology, Head and Neck Diseases 142 (2): 74–78. doi:1016/j.anorl.2024.11.005
Néant N., Lê M.P., Bouchet S., Lagoutte-Renosi J., Grégoire M., Parant F., Venisse N., Lalanne S., Lemaitre F., Muret P., Renou Q., Destere A., Gandia P., Flandre P., Peytavin G., Solas C., for the ANRS-MIE-CARLAPOP Study Group, Bailly B., Gendrin V., Klopfenstein T., Zayet S., Bozon F., Brunel A.-S., Hoen B., Hustache-Mathieu L., Hemssamfar M., Bonnet F., Piroth L., Buisson M., Mahy S., Duong M., Trabaud M.-A., Alfaiate D., Becker A., Braun E., Brunel F., Godinot M., Perpoint T., Javaux C., Colson P., Motte A., Obry-Roguet V., Brégigeon S., Faucher-Zaegel O., Laroche H., Dos Santos M., Ravaux I., Dhiver C., Tomei C., Ménard A., Million M., Philibert P., Psomas C., Berbescu S.-L., Michel C., Drumel T., Allavena C., Billaud E., Bouchez S., Brunet-Cartier C., Deschanvres C., Raffi F., Reliquet V., Querne G., Mear-Passard C., Asquier A., Moyon C., Beslon V., Collias L., Calvez V., Descamps D., Ferré V., Yazdan Y., Ghosn J., Pourcher V., Valantin M.-A., Plainchamp D., Benezit F., Arvieux C., Cheneau C., Ursenbach A., Hoellinger B., Melounou C., Rey D., Hansmann Y. (2026). Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study. Clinical Infectious Diseases 82 (1): 109–118. doi:1093/cid/ciaf385
Pachebat N., Mcheik J.N., Fieux M., Favier V., Binet A., Dufour X., Carsuzaa F. (2025). Objective Evaluation of Nasal Obstruction in Cleft Lip and Palate Patients: A Preliminary Study. Journal of Personalized Medicine 15 (9): 403. doi:3390/jpm15090403
Pointeaux L., Boutin D., Lefeuvre S. (2025). Levamisole associated with linear IgA dermatosis. Clinical Toxicology 63 (11): 1016–1018. doi:1080/15563650.2025.2543939
Robalo M., Ayraud-Thévenot S., Migeot V., Gourgues A.-S., Albouy M., Venisse N. (2025). Detection of Endocrine Disruptors in Human Placenta: A Pilot Study on Exposure and Histopathological Findings. Therapeutic Drug Monitoring. doi:1097/FTD.0000000000001414
